Probiotics in the add-on treatment of otitis media in clinical practice.

M Gelardi, I La Mantia, L Drago, G Meroni, S E Aragona, G Cupido, C Vicini, C Berardi, G Ciprandi

Journal: Journal of biological regulators and homeostatic agents 2021;34(6 Suppl. 1):19-26

PMID: 33426862

Abstract

Otitis media (OM) affects the middle ear and is typically characterized by earache. OM may be classified as acute (AOM) or chronic (COM), based on symptom duration. OM may be clinically suspected, but the diagnosis is usually confirmed by the otoscopy. Antibiotic therapy is frequently used in clinical practice. However, antibiotics often induce intestinal and respiratory dysbiosis associated with some clinical problems. A one-month course of a probiotic mixture (Abincol® containing Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 million living cells), and Lactobacillus delbrueckii LDD01 (200 million living cells), was prescribed in the Group A, and was compared with no addon treatment, such as the Group B. Patients were evaluated at baseline (T0), at the end of antibiotic treatment (T1), at the end of probiotic course (T2), and at the end of 3-month follow-up (T3).

Copyright 2020 Biolife Sas. www.biolifesas.org.

Address: Department of Otolaryngology, University of Foggia, Foggia, Italy.; Unit of Otolaryngology, Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.; Microbiology Department, University of Milan, Milan, Italy.; Center of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), Italy.; ENT Department, University of Palermo, Palermo, Italy.; ENT Department, Forlì-Faenza Hospital, Italy, University of Ferrara e Bologna.; ENT Department, Istituto Clinico Città Studi di Milano, Milan, Italy.; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.; The Italian Study Group on Upper Respiratory Infections.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.